A multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy of Tradipitant in relieving symptoms of gastroparesis

This is a phase IIa research study for patients with diabetic or idiopathic gastroparesis aged 18-70. Participants will remain on the study and continue to receive the study investigational medication or placebo until the study is completed. It is estimated that patients will participate for a minimum of 4 weeks. During this time, participants will be evaluated by the study team every two weeks.

Please input your information below, or call the research hotline at 612-870-5599 for additional information regarding gastroparesis studies.

ATTENTION: This form is not meant for transmitting medical, prescription or appointment information or to initiate direct communications with our health care providers. Calls of this nature will not be answered by email and should be directed to 612-871-1145. In the event of a medical emergency, dial 911. Emails are monitored Monday through Friday during regular business hours.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.